Digital holographic microscopy overcomes the limitations of in vitro nanomaterial cytotoxicity testing

The cytotoxic potential of nanomaterials is commonly evaluated by different cellular endpoints as reactive oxygen species formation, cell viability or cell death. Usually these parameters are determined by intensity based optical readouts that are often influenced by nanomaterial-based interferences. Here we present Digital Holographic Microscopy (DHM) as a multimodal optical method, which overcomes the limitations of conventional in vitro assays based on color or fluorescence read outs. Using cell viability WST8- and cell death LDH-assay we investigated the toxic effects of two representative silver nanomaterials. Therefore, we used a matrix of four cell lines representing different organ functions. Compared to conventional toxicity assays DHM allows time resolved proliferation monitoring which is free of assay system interactions. Also, information about time-dependent mechanisms can be obtained. Additionally, we have analyzed single macrophages for refractive index, cell volume and dry mass after the incubation to cytotoxic silver spheres. The refractive index decreased dose dependent, while cell volume and dry mass stayed constant. We therefore suggest the evaluation of these parameters in cytotoxicity assessment for further evaluation of their relevance under the applied conditions. This demonstrates DHM as valuable label-free tool for nanomaterial toxicity analysis.

[1]  Steffi Ketelhut,et al.  Continuous morphology and growth monitoring of different cell types in a single culture using quantitative phase microscopy , 2015, Optical Metrology.

[2]  Lang Tran,et al.  Comprehensive In Vitro Toxicity Testing of a Panel of Representative Oxide Nanomaterials: First Steps towards an Intelligent Testing Strategy , 2015, PloS one.

[3]  Sarah Mues,et al.  Novel optical approaches for label-free quantification of nano-cytotoxic effects , 2016, SPIE BiOS.

[4]  Steffi Ketelhut,et al.  Quantitative Stain-Free and Continuous Multimodal Monitoring of Wound Healing In Vitro with Digital Holographic Microscopy , 2014, PloS one.

[5]  Björn Kemper,et al.  Manipulating intracellular refractive index for contrast-enhanced digital holographic imaging of subcellular structures , 2011, BiOS.

[6]  Christian Depeursinge,et al.  Noninvasive characterization of the fission yeast cell cycle by monitoring dry mass with digital holographic microscopy. , 2009, Journal of biomedical optics.

[7]  Alexandra Kroll,et al.  Interference of engineered nanoparticles with in vitro toxicity assays , 2012, Archives of Toxicology.

[8]  Alexandra Kroll,et al.  Current in vitro methods in nanoparticle risk assessment: limitations and challenges. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[9]  Jérôme Parent,et al.  Label-free cytotoxicity screening assay by digital holographic microscopy. , 2013, Assay and drug development technologies.

[10]  Patrik Langehanenberg,et al.  Integral refractive index determination of living suspension cells by multifocus digital holographic phase contrast microscopy. , 2007, Journal of biomedical optics.

[11]  Steffi Ketelhut,et al.  Multimodal label-free growth and morphology characterization of different cell types in a single culture with quantitative digital holographic phase microscopy , 2015, Photonics West - Biomedical Optics.

[12]  D. Dirksen,et al.  Autofocusing in digital holographic phase contrast microscopy on pure phase objects for live cell imaging. , 2008, Applied optics.

[13]  Sarah Mues,et al.  Optical analysis of nanomaterial-cell interactions: flow cytometry and digital holographic microscopy , 2015, Optical Metrology.

[14]  Daniel Carl,et al.  Modular digital holographic microscopy system for marker free quantitative phase contrast imaging of living cells , 2006, SPIE Photonics Europe.

[15]  Alexandra Kroll,et al.  Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays , 2011, Particle and Fibre Toxicology.

[16]  Robert Nadon,et al.  Statistical practice in high-throughput screening data analysis , 2006, Nature Biotechnology.

[17]  Steffi Ketelhut,et al.  Multimodal label-free in vitro toxicity testing with digital holographic microscopy , 2014, Photonics Europe.

[18]  Björn Kemper,et al.  Virulence from vesicles: Novel mechanisms of host cell injury by Escherichia coli O104:H4 outbreak strain , 2015, Scientific Reports.

[19]  Steffi Ketelhut,et al.  Simplified setup for imaging with digital holographic microscopy and enhanced quantitative phase contrast by osmotic stimulation of living cells , 2011, BiOS.

[20]  Daniel Carl,et al.  Investigation of living pancreas tumor cells by digital holographic microscopy. , 2006, Journal of biomedical optics.